Effect of Pentoxifylline on Tumor Suppressor and Proto-Oncogene Apoptosis in Sperm

作者: David T. Maxwell , John D. Jacobson , Alan King , Philip J. Chan

DOI: 10.1023/A:1015725230011

关键词: Sense (molecular biology)DNATumor suppressor geneSpermMolecular biologyApoptosisPolymerasePrimer (molecular biology)BiologyDNA fragmentation

摘要: Purpose: Pentoxifylline (PTX), a methylxanthine phosphodiesterase inhibitor reduces superoxide anions responsible for DNA apoptosis. The null hypothesis was that PTX equally effective in reducing damage to specific cell genes. objective determine the integrity of BRCA1 tumor suppressor gene and c-myc proto-oncogene after PTX. Methods: Sperm (64 samples, 4 patients) were preincubated either 0 (control) or 3.6 mM (30 min), washed incubated h at 37 40°C heat shock activation. Single primer polymerase chain reactions (PCR) carried out on lysed sperm targeting exon 11 1. Control single-stranded (ssDNA) stained with 9 μM Hoechst 33342 (blue) while PTX-treated ssDNA SYBR Gold (green). Nytran membrane discs control hybridized PTX-derived ssDNA. Fluorescent images stored microarray design analyzed using ANOVA Students' t-test (P < 0.05) significance. Results:BRCA1 higher pretreatment (93.3 + 10.4 vs. 50.5 9.2; mean SEM). In contrast, there no difference (56.8 9.0 41.7 6.4). Sense antisense primers gave similar fragmentation results. Conclusions: data showed protected but not suggesting did protect different A possible explanation proto-oncogenes had more fragile sites. study involved disc chip assay assess separate PCR-amplified sense strands. results suggested both strands affected by pretreatment.

参考文章(30)
Samuel C. Pang, Philip J. Chan, Allen Lu, Effects of pentoxifylline on sperm motility and hyperactivation in normozoospermic and normokinetic semen. Fertility and Sterility. ,vol. 60, pp. 336- 343 ,(1993) , 10.1016/S0015-0282(16)56108-1
D T Bishop, D F Easton, D Ford, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 56, pp. 265- 271 ,(1995)
Elisabeth Steichen-Gersdorf, Holly H Gallion, Deborah Ford, Catherine Girodet, Douglas F Easton, Richard A DiCioccio, Gareth Evans, Margaret A Ponder, Carole Pye, S Mazoyer, Tetsuro Noguchi, Fabienne Karengueven, Hagay Sobol, A Hardouin, Yves-Jean Bignon, M Steven Piver, Simon A Smith, Bruce AJ Ponder, None, Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. American Journal of Human Genetics. ,vol. 55, pp. 870- 875 ,(1994)
A Kallioniemi, O. Kallioniemi, D Sudar, D Rutovitz, J. Gray, F Waldman, D Pinkel, Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors Science. ,vol. 258, pp. 818- 821 ,(1992) , 10.1126/SCIENCE.1359641
M. Schena, D. Shalon, R. W. Davis, P. O. Brown, Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray Science. ,vol. 270, pp. 467- 470 ,(1995) , 10.1126/SCIENCE.270.5235.467
GM Lenoir, H Lynch, P Watson, T Conway, J Lynch, S Narod, J Feunteun, Familial breast-ovarian cancer locus on chromosome 17q12-q23 The Lancet. ,vol. 338, pp. 82- 83 ,(1991) , 10.1016/0140-6736(91)90076-2
Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE and the Breast Cancer Linkage Consortium, None, Risks of cancer in BRCA1-mutation carriers The Lancet. ,vol. 343, pp. 692- 695 ,(1994) , 10.1016/S0140-6736(94)91578-4
M.J. Duffy, Cellular oncogenes and suppressor genes as prognostic markers in cancer. Clinical Biochemistry. ,vol. 26, pp. 439- 447 ,(1993) , 10.1016/0009-9120(93)80007-H
A. M. VAN FURTH, E. M. VERHARD‐SEIJMONSBERGEN, R. VAN FURTH, J. A. M. LANGERMANS, Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-α, IL-1β and IL-10 by human leucocytes Immunology. ,vol. 91, pp. 193- 196 ,(1997) , 10.1046/J.1365-2567.1997.00252.X
Rajesh K. Naz, Gyanendra Kumar, Brijinder S. Minhas, Expression and Role of c-myc Protooncogene in Murine Preimplantation Embryonic Development Journal of Assisted Reproduction and Genetics. ,vol. 11, pp. 208- 216 ,(1994) , 10.1007/BF02211810